For more information about how Halldale can add value to your marketing and promotional campaigns or to discuss event exhibitor and sponsorship opportunities, contact our team to find out more
The Americas -
holly.foster@halldale.com
Rest of World -
jeremy@halldale.com
3D Systems announced that the Food and Drug Administration(FDA) has provided 510(k) clearance to its new VSP Orthopaedics solution —enabling surgeons to obtain a clear 3D visualization of a patient's anatomy anddevelop a personalized surgical plan, prior to entering the operating room. Theexpansion of 3D Systems' VSP service-based approach into the field oforthopaedic surgery builds on its VSP technology and anatomic modelingleadership.
The new VSP Orthopaedics solution is available through OnkosSurgical's My3D Personalized Solutions Platform and enables surgeons to devisea precise plan for tumor resection that in some cases allows for thepreservation of the native joint. Virtual surgical planning of the patient's 3Danatomy allows the surgeon to essentially perform the surgery digitally beforeentering the operating room. Following the online planning session between 3DSystems' biomedical engineers and the surgeon, patient-specific models,personalized surgical tools, and instruments are designed and 3D printed foruse within the sterile field. In clinical applications where VSP is used today,the solutions have been shown to improve surgical accuracy and outcomes — savingtime in the operating room, which benefits both the surgeon and the patient.1,2,33D Systems fully expects that VSP Orthopaedics will deliver the same benefitsto orthopaedic surgeons and patients.
As a pioneer in the personalized medicine space, 3D Systemsestablished VSP in 2012 as a service-based approach to personalized surgery,combining expertise in medical image processing, surgical planning, design, and3D printing.
Sources: